Cancer · 1978 · 12 citations · 23 references
Life SciencesImmunologyPathologyCellular ImmunologyHypersensitivityImmunopathologyCell-mediated ImmunityDelayed-type HypersensitivityGranulomatous InflammationImmunopathology Of SkinCell-mediated Immunity DefectsDelayed-type Hypersensitivity GranulomasDose ResponseGranulomatous ReactionsLymphocytic InfiltratesMatched Control GroupSarcoid GranulomasSarcoid-like Reaction
Noncaseating, sarcoid-like granulomas were found in the tissues of 9 out of 31 patients with Hodgkin's disease. In vivo and in vitro cell-mediated immunity was evaluated in patients with and without granulomas and compared to a group of 20 normal controls. Hodgkin's disease patients of both groups showed a significantly reduced in vivo and in vitro response when compared to the control group. However, when patients in stages IIIB and IV were eliminated and patients in stages I, II, and IIIA examined separately, a positive skin test response to one or more antigens was elicited in 85.7% of patients with granulomas, while a markedly decreased-dose dependent response was observed in patients without granulomas. In vitro lymphocyte blastic transformation by phytohemagglutinin (PHA) was severely impaired in both groups of patients as determined by dose-responses curves. These results indicate that Hodgkin's disease patients with granulomas have a significantly better skin test response than those without granulomas.
23
Report of the Committee on Hodgkin's Disease Staging Classification.
Paul P. Carbone, Henry S. Kaplan, K. Musshoff et al. · PubMed · 1971 · 4.2K citations
Delayed hypersensitivity in Hodgkin's disease
Robert C. Young, Michael P. Corder, Harley A. Haynes et al. · The American Journal of Medicine · 1972 · 243 citations